NASDAQ: NRC - National Research Corporation

Доходность за полгода: -19.58%
Сектор: Healthcare

График акции National Research Corporation


О компании

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty.

Подробнее
The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, workforce engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

Основные параметры

Выручка 0.128
EBITDA 0.0481
Число акций ао 0.02467 млрд
P/E 52.88
P/S 13.39
P/BV 52.1
EV/EBITDA 36.02
Цена ао 39.7
ISIN US6373722023
Сайт https://www.nrchealth.com
Изменение цены за день: -0.6452% (34.1)
Изменение цены за неделю: -9.1% (37.27)
Изменение цены за месяц: -14.6% (39.67)
Изменение цены за 3 месяца: -13.53% (39.18)
Изменение цены за полгода: -19.58% (42.13)
Изменение цены за год: -23.68% (44.39)
Изменение цены с начала года: -15.02% (39.87)


Все параметры ⇨

Оценка

Недооценка

Название Значение Оценка
P/S 13.39 1
P/BV 52.1 1
P/E 52.88 5
EV/EBITDA 36.02 5
Итого:

Эффективность

Название Значение Оценка
ROA, % 24.49 7
ROE, % 51.2 10
Итого:

Дивиденды

Название Значение Оценка
Div yield, % 1.1936 2
DSI 0.86 9
Итого:

Долг

Название Значение Оценка
Debt/EBITDA 0.8478 9
Итого:

Импульс роста

Название Значение Оценка
Рост прибыли, % 5.14 1
Рост цены акции, % 0 0
Рост дивидендов, % 44.14 9
Итого:

Дивиденды

Дивиденды, % Дивиденды По итогам периода Купить до Дата закрытия реестра Выплата до
0.3% 0.12 IV кв. 2023 25.03.2024 27.03.2024 11.04.2024
0.29% 0.12 III кв. 2023 26.12.2023 28.12.2023 12.01.2024

Основные владельцы

Институционалы Объем Доля, %
Kayne Anderson Rudnick Investment Management LLC 2881464 12.08
Blackrock Inc. 1065585 4.47
Morgan Stanley 943710 3.96
Vanguard Group Inc 934644 3.92
Conestoga Capital Advisors, LLC 780806 3.27
Dimensional Fund Advisors LP 636402 2.67
QV Investors Inc. 395102 1.66
Renaissance Technologies, LLC 373584 1.57
Geode Capital Management, LLC 356305 1.49
State Street Corporation 342475 1.44

Похожие компании



Руководство компании

Руководитель Должность Оплата Год рождения
Mr. Michael D. Hays Founder, CEO, President & Director 131.65k 1955 (69 лет)
Mr. Kevin R. Karas CPA Senior VP of Finance, CFO, Treasurer & Secretary 292.81k 1958 (66 лет)
Ms. Helen L. Hrdy Chief Customer Officer 291.31k 1966 (58 лет)
Mr. Jon Boumstein Chief Delivery Officer N/A
Dr. Gregory Makoul M.S., Ph.D. Chief Transformation Officer N/A
Linda Stacy Vice President of Finance N/A
Megan Charko Senior Manager of Content Marketing N/A
Mr. Christophe Louvion Chief Product & Technology Officer N/A
Mr. Andy Monnich Chief Corporate Development Officer N/A
Mr. Jason Hahn Chief Revenue Officer N/A

Информация о компании

Адрес: United States, Lincoln. NE, 1245 Q Street - открыть в Google картах, открыть Яндекс картах
Сайт: https://www.nrchealth.com
Телефон: +tel:4024752525